Review





Similar Products

99
New England Biolabs purexpress
Purexpress, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vitro+assays/PURExpress+In+Vitro+Protein+Synthesis+Kit/pm42827202-355-8-14
Average 99 stars, based on 1 article reviews
purexpress - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

96
Jackson Immuno vitro jackson immunoresearch
Vitro Jackson Immunoresearch, supplied by Jackson Immuno, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vitro+assays/Bovine+Serum+Albumin/pm42805170-927-116-118
Average 96 stars, based on 1 article reviews
vitro jackson immunoresearch - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

99
New England Biolabs purexpress in vitro protein synthesis kit
Purexpress In Vitro Protein Synthesis Kit, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vitro+assays/PURExpress+In+Vitro+Protein+Synthesis+Kit/pm42793143-60-31-37
Average 99 stars, based on 1 article reviews
purexpress in vitro protein synthesis kit - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

96
New England Biolabs vitro transcription
Vitro Transcription, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vitro+assays/EnGen+sgRNA+Synthesis+Kit%2C+S%2E+pyogenes/pm42789393-1148-59-61
Average 96 stars, based on 1 article reviews
vitro transcription - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

99
New England Biolabs purexpress kit
Purexpress Kit, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vitro+assays/PURExpress+In+Vitro+Protein+Synthesis+Kit/bio_rxiv__64898__2026__09__18__752725-298-8-10
Average 99 stars, based on 1 article reviews
purexpress kit - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

95
TaKaRa sgrna transcription kit
Sgrna Transcription Kit, supplied by TaKaRa, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vitro+assays/Guide-it+sgRNA+In+Vitro+Transcription+Kit/pm42684483-59-8-11
Average 95 stars, based on 1 article reviews
sgrna transcription kit - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

97
Cytoskeleton Inc vitro rhoa activity
(A) Nup93 knockdown significantly increases endothelial <t>RhoA</t> protein levels (representative experiment shown in technical triplicates). Quantified in (B, t-test, each dot a biological experiment [averaged technical triplicates] ).(C) Loss of Nup93 also <t>increases</t> <t>GTP-loaded</t> RhoA levels to indicate heightened RhoA activity (t-test, each dot a biological experiment performed in technical duplicates). (D) shNup93-transduced ECs treated with Y-27632 (10µM; 24hrs) exhibit decreased streptavidin staining, less stress fiber formation, and enhanced VE-cadherin junctional intensity. Representative images shown. Scale bars=50µm. Quantified in (E-G, each dot a biological experiment performed in technical triplicates, 2-Way ANOVA followed by Tukey’s ) . ( H) Y-27632 treatment in Nup93-deficient ECs reduces cellular stiffness, as AFM readouts indicate values similar to that of control conditions. (n=3, 8 reads per group/expt, 2-Way ANOVA followed by Tukey’s). (I) Y-27632 treatment in Nup93-depleted ECs partially rescues both phosphorylated and total eNOS levels, whereas Nup93 remains unaffected. Representative experiment shown in technical duplicates. Quantified in (J-L , n=3, 2-Way ANOVA followed by Tukey’s, each dot a biological experiment [averaged technical duplicates] ). (M) Conditioned media from Y-27632-treated Nup93-deficient ECs show a partial albeit significant restoration in secreted NO levels. (n=3, each dot a biological experiment [averaged technical duplicates], 2-Way ANOVA followed by Tukey’s).
Vitro Rhoa Activity, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vitro+assays/RhoA+G-LISA+GTPase+Activation+Assay+Kit/pmc13371109-144-1-23
Average 97 stars, based on 1 article reviews
vitro rhoa activity - by Bioz Stars, 2026-10
97/100 stars
  Buy from Supplier

96
MedChemExpress handling in vitro 420 rimiducid
(A) Nup93 knockdown significantly increases endothelial <t>RhoA</t> protein levels (representative experiment shown in technical triplicates). Quantified in (B, t-test, each dot a biological experiment [averaged technical triplicates] ).(C) Loss of Nup93 also <t>increases</t> <t>GTP-loaded</t> RhoA levels to indicate heightened RhoA activity (t-test, each dot a biological experiment performed in technical duplicates). (D) shNup93-transduced ECs treated with Y-27632 (10µM; 24hrs) exhibit decreased streptavidin staining, less stress fiber formation, and enhanced VE-cadherin junctional intensity. Representative images shown. Scale bars=50µm. Quantified in (E-G, each dot a biological experiment performed in technical triplicates, 2-Way ANOVA followed by Tukey’s ) . ( H) Y-27632 treatment in Nup93-deficient ECs reduces cellular stiffness, as AFM readouts indicate values similar to that of control conditions. (n=3, 8 reads per group/expt, 2-Way ANOVA followed by Tukey’s). (I) Y-27632 treatment in Nup93-depleted ECs partially rescues both phosphorylated and total eNOS levels, whereas Nup93 remains unaffected. Representative experiment shown in technical duplicates. Quantified in (J-L , n=3, 2-Way ANOVA followed by Tukey’s, each dot a biological experiment [averaged technical duplicates] ). (M) Conditioned media from Y-27632-treated Nup93-deficient ECs show a partial albeit significant restoration in secreted NO levels. (n=3, each dot a biological experiment [averaged technical duplicates], 2-Way ANOVA followed by Tukey’s).
Handling In Vitro 420 Rimiducid, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vitro+assays/Rimiducid/10__1016_slash_j__omton__2026__201315-195-5-11
Average 96 stars, based on 1 article reviews
handling in vitro 420 rimiducid - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

99
MedChemExpress vitro cultured fat body tissues
(A) Nup93 knockdown significantly increases endothelial <t>RhoA</t> protein levels (representative experiment shown in technical triplicates). Quantified in (B, t-test, each dot a biological experiment [averaged technical triplicates] ).(C) Loss of Nup93 also <t>increases</t> <t>GTP-loaded</t> RhoA levels to indicate heightened RhoA activity (t-test, each dot a biological experiment performed in technical duplicates). (D) shNup93-transduced ECs treated with Y-27632 (10µM; 24hrs) exhibit decreased streptavidin staining, less stress fiber formation, and enhanced VE-cadherin junctional intensity. Representative images shown. Scale bars=50µm. Quantified in (E-G, each dot a biological experiment performed in technical triplicates, 2-Way ANOVA followed by Tukey’s ) . ( H) Y-27632 treatment in Nup93-deficient ECs reduces cellular stiffness, as AFM readouts indicate values similar to that of control conditions. (n=3, 8 reads per group/expt, 2-Way ANOVA followed by Tukey’s). (I) Y-27632 treatment in Nup93-depleted ECs partially rescues both phosphorylated and total eNOS levels, whereas Nup93 remains unaffected. Representative experiment shown in technical duplicates. Quantified in (J-L , n=3, 2-Way ANOVA followed by Tukey’s, each dot a biological experiment [averaged technical duplicates] ). (M) Conditioned media from Y-27632-treated Nup93-deficient ECs show a partial albeit significant restoration in secreted NO levels. (n=3, each dot a biological experiment [averaged technical duplicates], 2-Way ANOVA followed by Tukey’s).
Vitro Cultured Fat Body Tissues, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vitro+assays/BODIPY+493%2F503/pm42477655-214-10-28
Average 99 stars, based on 1 article reviews
vitro cultured fat body tissues - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

Image Search Results


(A) Nup93 knockdown significantly increases endothelial RhoA protein levels (representative experiment shown in technical triplicates). Quantified in (B, t-test, each dot a biological experiment [averaged technical triplicates] ).(C) Loss of Nup93 also increases GTP-loaded RhoA levels to indicate heightened RhoA activity (t-test, each dot a biological experiment performed in technical duplicates). (D) shNup93-transduced ECs treated with Y-27632 (10µM; 24hrs) exhibit decreased streptavidin staining, less stress fiber formation, and enhanced VE-cadherin junctional intensity. Representative images shown. Scale bars=50µm. Quantified in (E-G, each dot a biological experiment performed in technical triplicates, 2-Way ANOVA followed by Tukey’s ) . ( H) Y-27632 treatment in Nup93-deficient ECs reduces cellular stiffness, as AFM readouts indicate values similar to that of control conditions. (n=3, 8 reads per group/expt, 2-Way ANOVA followed by Tukey’s). (I) Y-27632 treatment in Nup93-depleted ECs partially rescues both phosphorylated and total eNOS levels, whereas Nup93 remains unaffected. Representative experiment shown in technical duplicates. Quantified in (J-L , n=3, 2-Way ANOVA followed by Tukey’s, each dot a biological experiment [averaged technical duplicates] ). (M) Conditioned media from Y-27632-treated Nup93-deficient ECs show a partial albeit significant restoration in secreted NO levels. (n=3, each dot a biological experiment [averaged technical duplicates], 2-Way ANOVA followed by Tukey’s).

Journal: Arteriosclerosis, thrombosis, and vascular biology

Article Title: Endothelial Nucleoporin93 (Nup93) Maintains Vascular Homeostasis via Sun1-Dependent Regulation of RhoA/ROCK activity

doi: 10.1161/ATVBAHA.126.324964

Figure Lengend Snippet: (A) Nup93 knockdown significantly increases endothelial RhoA protein levels (representative experiment shown in technical triplicates). Quantified in (B, t-test, each dot a biological experiment [averaged technical triplicates] ).(C) Loss of Nup93 also increases GTP-loaded RhoA levels to indicate heightened RhoA activity (t-test, each dot a biological experiment performed in technical duplicates). (D) shNup93-transduced ECs treated with Y-27632 (10µM; 24hrs) exhibit decreased streptavidin staining, less stress fiber formation, and enhanced VE-cadherin junctional intensity. Representative images shown. Scale bars=50µm. Quantified in (E-G, each dot a biological experiment performed in technical triplicates, 2-Way ANOVA followed by Tukey’s ) . ( H) Y-27632 treatment in Nup93-deficient ECs reduces cellular stiffness, as AFM readouts indicate values similar to that of control conditions. (n=3, 8 reads per group/expt, 2-Way ANOVA followed by Tukey’s). (I) Y-27632 treatment in Nup93-depleted ECs partially rescues both phosphorylated and total eNOS levels, whereas Nup93 remains unaffected. Representative experiment shown in technical duplicates. Quantified in (J-L , n=3, 2-Way ANOVA followed by Tukey’s, each dot a biological experiment [averaged technical duplicates] ). (M) Conditioned media from Y-27632-treated Nup93-deficient ECs show a partial albeit significant restoration in secreted NO levels. (n=3, each dot a biological experiment [averaged technical duplicates], 2-Way ANOVA followed by Tukey’s).

Article Snippet: In vitro RhoA activity was determined by measuring the level of guanosine triphosphate (GTP)-bound RhoA in cultured cells according to the manufacturer’s instructions (Cytoskeleton, BK124).

Techniques: Activity Assay, Knockdown, Staining, Control

(A) Endothelial knockdown of Nup93 leads to a selective loss in Sun1 protein expression, whereas Sun2 protein levels remain unchanged. Representative experiment shown in technical triplicates. Quantified in (B) and (C). ( t-test, each dot a biological experiment [averaged technical triplicates]) (D) Schematic: Primary human ECs were first transduced with shNup93 (or shEmpty controls) for targeted knockdown of Nup93. Lentiviral-based methods were then used to express a human Sun1-FLAG construct (or Empty) for exogenous Sun1 expression. (E) Immunoblot analyses indicate successful restoration of Sun1 protein levels in Nup93-deficient ECs, as Sun1 levels are comparable to that of healthy control ECs. Sun2 and Nup93 protein levels, however, remain unaffected. RhoA protein levels also remain elevated despite exogenous Sun1 protein. Representative experiment shown with select groups performed in technical duplicates. Quantified in (F-I , n=3, each dot a biological experiment with select groups performed in technical duplicates, 2-Way ANOVA followed by Tukey’s ). (J) RhoA activity is, however, significantly attenuated with Sun1 re-introduction in Nup93 knockdown ECs. (n=3, each dot a biological experiment [averaged technical duplicates], 2-Way ANOVA followed by Tukey’s).

Journal: Arteriosclerosis, thrombosis, and vascular biology

Article Title: Endothelial Nucleoporin93 (Nup93) Maintains Vascular Homeostasis via Sun1-Dependent Regulation of RhoA/ROCK activity

doi: 10.1161/ATVBAHA.126.324964

Figure Lengend Snippet: (A) Endothelial knockdown of Nup93 leads to a selective loss in Sun1 protein expression, whereas Sun2 protein levels remain unchanged. Representative experiment shown in technical triplicates. Quantified in (B) and (C). ( t-test, each dot a biological experiment [averaged technical triplicates]) (D) Schematic: Primary human ECs were first transduced with shNup93 (or shEmpty controls) for targeted knockdown of Nup93. Lentiviral-based methods were then used to express a human Sun1-FLAG construct (or Empty) for exogenous Sun1 expression. (E) Immunoblot analyses indicate successful restoration of Sun1 protein levels in Nup93-deficient ECs, as Sun1 levels are comparable to that of healthy control ECs. Sun2 and Nup93 protein levels, however, remain unaffected. RhoA protein levels also remain elevated despite exogenous Sun1 protein. Representative experiment shown with select groups performed in technical duplicates. Quantified in (F-I , n=3, each dot a biological experiment with select groups performed in technical duplicates, 2-Way ANOVA followed by Tukey’s ). (J) RhoA activity is, however, significantly attenuated with Sun1 re-introduction in Nup93 knockdown ECs. (n=3, each dot a biological experiment [averaged technical duplicates], 2-Way ANOVA followed by Tukey’s).

Article Snippet: In vitro RhoA activity was determined by measuring the level of guanosine triphosphate (GTP)-bound RhoA in cultured cells according to the manufacturer’s instructions (Cytoskeleton, BK124).

Techniques: Activity Assay, Knockdown, Expressing, Transduction, Construct, Western Blot, Control